Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study

BACKGROUND: Recent data suggest that anti-TNF doses can be reduced in ankylosing spondylitis (AS) patients. Some authors even propose withdrawing treatment in patients in clinical remission; however, at present there is no evidence to support this. OBJECTIVE: To assess how long AS patients with pers...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Arthritis Res Ther
Autors principals: Moreno, Mireia, Gratacós, Jordi, Torrente-Segarra, Vicenç, Sanmarti, Raimon, Morlà, Rosa, Pontes, Caridad, Llop, Maria, Juanola, Xavier
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451276/
https://ncbi.nlm.nih.gov/pubmed/30953541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1873-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars